会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明专利
    • DK456585D0
    • 1985-10-07
    • DK456585
    • 1985-10-07
    • KOEPF MAIER PETRAKOEPF HARTMUTNEUSE EBERHARD WILHELM
    • KOEPF-MAIER PETRAKOEPF HARTMUTNEUSE EBERHARD WILHELM
    • C07F17/00A61K31/28A61K31/295A61P35/00C07F17/02C07F
    • PCT No. PCT/EP85/00047 Sec. 371 Date Oct. 3, 1985 Sec. 102(e) Date Oct. 3, 1985 PCT Filed Feb. 8, 1985 PCT Pub. No. WO85/03507 PCT Pub. Date Aug. 15, 1985.Metallicenium salts of the general formula I [( eta 5-C5H-xRx)M( eta 5-C5H5-yR'y)]am+[A]bn-(I) in which M is Fe, Co, Ni, Ru or Os; C5H5-xRx and C5H5-yR'y denote cyclopendadienyl rings which, independently of one another, can be unsubstituted (x and y=0) or mono-, di-, tri-, tetra- or penta-substituted (x and y=1, 2, 3, 4 or 5), and in which R and R' independently of one another represent identical or different substituents and denote alkyl, cycloalkyl, hydroxyalkyl, aminoalkyl, halogenoalkyl, alkenyl, aryl, aralkyl, ferrocenyl, ferrocenylium, ferrocenylalkyl, acyl, halogenyl, trialkylsilyl, tricycloalkylsilyl, triarylsilyl, triaralkylsilyl or carboxyl, ester, amide or hydrazide groups, or R and R' together form an alkylene bridge with 2 to 4 bridge atoms; a, b, m and n are integers, and m has the value 1 or 2, n has the value 1, 2 or 3 and axm=bxn; and A is a complexating or very bulky anion which stabilizes the metallicenium cation; and solvates of these salts, for use as medicaments, in paticular as cytostatics in combating tumors susceptible thereto.
    • 26. 发明专利
    • FI853818A0
    • 1985-10-02
    • FI853818
    • 1985-10-02
    • KOEPF MAIER PETRAKOEPF HARTMUTNEUSE EBERHARD WILHELM
    • KOEPF-MAIER PETRAKOEPF HARTMUTNEUSE EBERHARD WILHELM
    • C07F17/00A61K31/28A61K31/295A61P35/00C07F17/02C07F
    • PCT No. PCT/EP85/00047 Sec. 371 Date Oct. 3, 1985 Sec. 102(e) Date Oct. 3, 1985 PCT Filed Feb. 8, 1985 PCT Pub. No. WO85/03507 PCT Pub. Date Aug. 15, 1985.Metallicenium salts of the general formula I [( eta 5-C5H-xRx)M( eta 5-C5H5-yR'y)]am+[A]bn-(I) in which M is Fe, Co, Ni, Ru or Os; C5H5-xRx and C5H5-yR'y denote cyclopendadienyl rings which, independently of one another, can be unsubstituted (x and y=0) or mono-, di-, tri-, tetra- or penta-substituted (x and y=1, 2, 3, 4 or 5), and in which R and R' independently of one another represent identical or different substituents and denote alkyl, cycloalkyl, hydroxyalkyl, aminoalkyl, halogenoalkyl, alkenyl, aryl, aralkyl, ferrocenyl, ferrocenylium, ferrocenylalkyl, acyl, halogenyl, trialkylsilyl, tricycloalkylsilyl, triarylsilyl, triaralkylsilyl or carboxyl, ester, amide or hydrazide groups, or R and R' together form an alkylene bridge with 2 to 4 bridge atoms; a, b, m and n are integers, and m has the value 1 or 2, n has the value 1, 2 or 3 and axm=bxn; and A is a complexating or very bulky anion which stabilizes the metallicenium cation; and solvates of these salts, for use as medicaments, in paticular as cytostatics in combating tumors susceptible thereto.